CR GROUP L.P. sold 49.5% of their position (6.34M shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market sale worth $1.90M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 9/25/2023ACC: 0001209191-23-050530
-6.34M
Net shares
Net seller
$1.90M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
6.34M disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−2.53M
Price / share
$0.30
Trade value
$761.69K
% of position
21.0%
9/21/2023
12.07M→9.54M
Common Stock
Indirect
Shares
−1.58M
Price / share
$0.30
Trade value
$474.31K
% of position
21.0%
9/21/2023
7.52M→5.94M
Common Stock
Indirect
Shares
−506.95K
Price / share
$0.30
Trade value
$152.34K
% of position
21.0%
9/21/2023
2.41M→1.91M
Common Stock
Indirect
Shares
−1.72M
Price / share
$0.30
Trade value
$516.29K
% of position
21.0%
9/21/2023
8.18M→6.47M
Total
Net shares
−6.34M
Net value
-$1.90M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/21/2023 | S · Sale | −2.53M | $0.30 | $761.69K | 21.0% | 12.07M | 9.54M |
| Common Stock Indirect | 9/21/2023 | S · Sale | −1.58M | $0.30 | $474.31K | 21.0% | 7.52M | 5.94M |
| Common Stock Indirect | 9/21/2023 | S · Sale | −506.95K | $0.30 | $152.34K | 21.0% | 2.41M | 1.91M |
| Common Stock Indirect | 9/21/2023 | S · Sale | −1.72M | $0.30 | $516.29K | 21.0% | 8.18M | 6.47M |
| Total | −6.34M | -$1.90M | ||||||
Derivative Transactions0
No derivative transactions reported